Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
TELA Bio, Inc. - Common stock
(NQ:
TELA
)
0.6775
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about TELA Bio, Inc. - Common stock
< Previous
1
2
3
4
5
6
7
Next >
TELA Bio Reports First Quarter 2023 Financial Results
May 11, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Earnings Scheduled For May 11, 2023
↗
May 11, 2023
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its...
Via
Benzinga
Why TELA Bio Stock Is Dropping Today
↗
April 19, 2023
TELA Bio (NASDAQ: TELA) shares are trading lower after the company priced a 4.75 million share offering at $9.50 per share.
Via
Benzinga
Preview: TELA Bio's Earnings
↗
March 20, 2023
Via
Benzinga
TELA Bio Supports Diversity and Inclusion at International Hernia Collaboration Conference
May 09, 2023
Leader in innovative soft-tissue tissue reconstruction solutions sponsors event advocating for and mentoring women in surgery
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 08, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Participate in the JMP Securities Life Sciences Conference
May 02, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce First Quarter 2023 Financial Results
April 27, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Pricing of Public Offering of Common Stock
April 18, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Proposed Public Offering of Common Stock
April 18, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio’s OviTex® Reinforced Tissue Matrix to be Featured in Three Case Reports at SAGES 2023
March 29, 2023
Presentations highlight utility of this advanced hernia reinforcement material for robotic procedures
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces 510(k) Clearance for OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
March 23, 2023
Company continues design advancements of biologic-based materials for soft tissue repair and reinforcement
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Reports Fourth Quarter and Full Year 2022 Financial Results
March 21, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 21, 2023
↗
March 21, 2023
Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.20 per share on revenue of $41.75 million.
Via
Benzinga
TELA Bio Highlights Published Clinical Research from 2022 Showcasing Safety and Performance of Reinforced Biologic for Hernia Indications
March 16, 2023
Recent research of OviTex® Reinforced Tissue Matrix demonstrated favorable results in various hernia and abdominal wall reconstruction applications
From
TELA Bio, Inc.
Via
GlobeNewswire
Elon Musk A Frequent Flier In 2022 With Flights Lasting As Little As 13 Minutes, Says Report: His Love For Jet-Setting At Odds With Tesla's Climate Stance?
↗
March 06, 2023
Tesla Inc. (NASDAQ: TELA) CEO Elon Musk is an entrepreneur who has his fingers in many pies, and undoubtedly time is money for him.
Via
Benzinga
TELA Bio to Announce Fourth Quarter and Full Year 2022 Financial Results
February 28, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 24, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces U.S. Commercial Launch of Two New OviTex® LPR Device Configurations to Repair Large Abdominal Hernias Using Robotic and Laparoscopic Techniques
February 21, 2023
Company continues to expand innovative product portfolio to address surgeon needs
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Awarded Biosynthetic Mesh Products Agreement with a National Group Purchasing Organization
February 14, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 20, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces U.S. Commercial Launch of NIVIS™ Fibrillar Collagen Pack, The Natural Restoration Solution to Support Healing of Surgical Wounds
January 09, 2023
Company grows product portfolio, expanding product offerings to optimize soft tissue preservation and restoration
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Participate in the 41st Annual J.P. Morgan Healthcare Conference
December 21, 2022
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 09, 2022
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Participate in Piper Sandler 34th Annual Healthcare Conference
November 21, 2022
From
TELA Bio, Inc.
Via
GlobeNewswire
Coinbase To $80? Plus Deutsche Bank Cuts PT On This Stock By 80%
↗
November 10, 2022
Citigroup cut the price target on Coinbase Global, Inc. (NASDAQ: COIN) from $105 to $80. Citigroup analyst Peter Christiansen maintained a Buy rating on the stock. Coinbase shares rose 2.1% to $46.95...
Via
Benzinga
TELA Bio Reports Third Quarter 2022 Financial Results
November 09, 2022
From
TELA Bio, Inc.
Via
GlobeNewswire
Earnings Outlook For TELA Bio
↗
November 08, 2022
TELA Bio (NASDAQ:TELA) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that TELA Bio will...
Via
Benzinga
TELA Bio to Participate in Canaccord MedTech, Diagnostics and Digital Health & Services Forum
November 03, 2022
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 28, 2022
From
TELA Bio, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
